Breakthrough in ALS Treatment: Tofersen Significantly Slows Disease Progression in SOD1 Mutation Patient
Amyotrophic Lateral Sclerosis (ALS), commonly known as Lou Gehrig’s disease, is recognized by the World Health Organization (WHO) as one of the five major incurable diseases. It is the most common motorRead More…